Name | Number of supported studies | Average coverage | |
---|---|---|---|
classical monocyte | 6 studies | 29% ± 13% | |
epithelial cell | 6 studies | 30% ± 16% | |
fibroblast | 6 studies | 26% ± 12% | |
myeloid cell | 4 studies | 27% ± 6% | |
endothelial cell | 4 studies | 25% ± 5% | |
macrophage | 4 studies | 22% ± 6% | |
endothelial cell of vascular tree | 4 studies | 33% ± 14% | |
squamous epithelial cell | 3 studies | 29% ± 19% | |
conventional dendritic cell | 3 studies | 32% ± 17% | |
astrocyte | 3 studies | 23% ± 8% | |
pancreatic A cell | 3 studies | 27% ± 8% |
Insufficient scRNA-seq data for expression of MAFG at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 3695.89 | 1445 / 1445 | 100% | 35.85 | 183 / 183 |
intestine | 100% | 3544.70 | 966 / 966 | 100% | 27.90 | 527 / 527 |
stomach | 100% | 2676.03 | 359 / 359 | 100% | 27.01 | 286 / 286 |
lung | 100% | 4974.78 | 578 / 578 | 100% | 30.47 | 1153 / 1155 |
skin | 100% | 2662.06 | 1809 / 1809 | 100% | 39.84 | 471 / 472 |
brain | 100% | 3326.76 | 2640 / 2642 | 100% | 31.46 | 704 / 705 |
thymus | 100% | 3539.76 | 652 / 653 | 98% | 20.03 | 595 / 605 |
breast | 100% | 2293.52 | 459 / 459 | 98% | 18.42 | 1094 / 1118 |
uterus | 100% | 3406.16 | 170 / 170 | 98% | 22.44 | 449 / 459 |
prostate | 100% | 2817.59 | 244 / 245 | 98% | 15.91 | 492 / 502 |
kidney | 100% | 2569.35 | 89 / 89 | 97% | 18.19 | 876 / 901 |
bladder | 100% | 4120.43 | 21 / 21 | 97% | 22.18 | 489 / 504 |
ovary | 100% | 2976.96 | 180 / 180 | 96% | 12.61 | 411 / 430 |
pancreas | 97% | 1252.24 | 317 / 328 | 98% | 22.78 | 174 / 178 |
adrenal gland | 100% | 2756.28 | 258 / 258 | 93% | 23.78 | 214 / 230 |
liver | 94% | 1303.23 | 213 / 226 | 79% | 11.27 | 320 / 406 |
adipose | 100% | 2697.29 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 3387.03 | 1335 / 1335 | 0% | 0 | 0 / 0 |
muscle | 100% | 5452.71 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 3517.09 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 22.99 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 7.22 | 1 / 1 |
heart | 99% | 2592.62 | 851 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 99% | 22.94 | 79 / 80 |
peripheral blood | 98% | 3135.75 | 906 / 929 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 97% | 15.47 | 28 / 29 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0010628 | Biological process | positive regulation of gene expression |
GO_0030534 | Biological process | adult behavior |
GO_0000122 | Biological process | negative regulation of transcription by RNA polymerase II |
GO_0001701 | Biological process | in utero embryonic development |
GO_0042127 | Biological process | regulation of cell population proliferation |
GO_0045604 | Biological process | regulation of epidermal cell differentiation |
GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
GO_0090575 | Cellular component | RNA polymerase II transcription regulator complex |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005634 | Cellular component | nucleus |
GO_1990837 | Molecular function | sequence-specific double-stranded DNA binding |
GO_0000978 | Molecular function | RNA polymerase II cis-regulatory region sequence-specific DNA binding |
GO_0001228 | Molecular function | DNA-binding transcription activator activity, RNA polymerase II-specific |
GO_0003700 | Molecular function | DNA-binding transcription factor activity |
GO_0005515 | Molecular function | protein binding |
GO_0000981 | Molecular function | DNA-binding transcription factor activity, RNA polymerase II-specific |
GO_0042802 | Molecular function | identical protein binding |
Gene name | MAFG |
Protein name | Transcription factor MafG (V-maf musculoaponeurotic fibrosarcoma oncogene homolog G) (hMAF) Transcription factor MafG (V-maf musculoaponeurotic fibrosarcoma oncogene homolog G) |
Synonyms | |
Description | FUNCTION: Since they lack a putative transactivation domain, the small Mafs behave as transcriptional repressors when they dimerize among themselves . However, they seem to serve as transcriptional activators by dimerizing with other (usually larger) basic-zipper proteins, such as NFE2, NFE2L1 and NFE2L2, and recruiting them to specific DNA-binding sites . Small Maf proteins heterodimerize with Fos and may act as competitive repressors of the NFE2L2 transcription factor . Transcription factor, component of erythroid-specific transcription factor NFE2L2 . Activates globin gene expression when associated with NFE2L2 . May be involved in signal transduction of extracellular H(+) (By similarity). . |
Accessions | I3L2F8 ENST00000392366.7 ENST00000574686.1 ENST00000357736.9 O15525 |